Abstract
The association of genetic variation with tissue-specific gene expression and alternative splicing guides functional characterization of complex trait-associated loci and may suggest novel genes implicated in disease. Here, our aims were as follows: (1) to generate reference profiles of colon mucosa gene expression and alternative splicing and compare them across colon subsites (ascending, transverse, and descending), (2) to identify expression and splicing quantitative trait loci (QTLs), (3) to find traits for which identified QTLs contribute to single-nucleotide polymorphism (SNP)-based heritability, (4) to propose candidate effector genes, and (5) to provide a web-based visualization resource.
Methods
We collected colonic mucosal biopsy specimens from 485 healthy adults and performed bulk RNA sequencing. We performed genome-wide SNP genotyping from blood leukocytes. Statistical approaches and bioinformatics software were used for QTL identification and downstream analyses.
Results
We provided a complete quantification of gene expression and alternative splicing across colon subsites and described their differences. We identified thousands of expression and splicing QTLs and defined their enrichment at genome-wide regulatory regions. We found that part of the SNP-based heritability of diseases affecting colon tissue, such as colorectal cancer and inflammatory bowel disease, but also of diseases affecting other tissues, such as psychiatric conditions, can be explained by the identified QTLs. We provided candidate effector genes for multiple phenotypes. Finally, we provided the Colon Transcriptome Explorer web application.
Conclusions
We provide a large characterization of gene expression and splicing across colon subsites. Our findings provide greater etiologic insight into complex traits and diseases influenced by transcriptomic changes in colon tissue.
| Original language | English |
|---|---|
| Pages (from-to) | 181-197 |
| Number of pages | 17 |
| Journal | Cellular and Molecular Gastroenterology and Hepatology (CMGH) |
| Volume | 12 |
| Issue number | 1 |
| Early online date | 16 Feb 2021 |
| DOIs | |
| Publication status | Published - 2021 |
| Externally published | Yes |
Funding
Funding Supported by the Agency for Management of University and Research Grants of the Catalan Government grants 2017SGR723; the Instituto de Salud Carlos III, co-funded by European Regional Development Fund (FEDER) funds ?A Way to Build Europe? grants PI14-00613, PI17-00092; the Spanish Association Against Cancer Scientific Foundation grant GCTRA18022MORE; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) CB07/02/2005; and the National Institutes of Health grants R01CA204279, R01CA143237, and R01CA201407. Also supported by EU H2020 - Marie Sk?odowska-Curie (MSC) grant 796216 (R.C.T.); a postdoctoral fellowship through the ?Fundaci?n Cient?fica de la Asociaci?n Espa?ola Contra el C?ncer (AECC)? (M.O.S.); the National Institutes of Health training grant T32 5T32CA163177-07 (C.H.D.); and the Ministerio de Universidades through predoctoral fellowship number FPU16/00599 for the ?Formaci?n del Profesorado Universitario? (V.D.O.). A sample collection of this work was supported by the Xarxa de Bancs de Tumors de Catalunya (XBTC) sponsored by Pla Director d'Oncologia de Catalunya, ?Plataforma Biobancos PT13/0010/0013,? and the Biobank of the Catalan Institute of Oncology (ICOBIOBANC), sponsored by the Catalan Institute of Oncology. This work was supported in part by National Institutes of Health/National Cancer Institute grants CA143237 and CA204279 (G.C.).The authors thank the ?Centres de Recerca de Catalunya? (CERCA) Program, Generalitat de Catalunya for institutional support. The authors particularly acknowledge the patients participating in this study, the endoscopy units from the Bellvitge University Hospital and the Viladecans Hospital, as well as Carmen Atencia, Judith Rocamora, Susana Lopez, Gemma Aiza, and the Biobank, Bellvitge University Hospital, Catalan Institute of Oncology Bellvitge Biomedical Research Institute (HUB-ICO-IDIBELL) (PT17/0015/0024) for their collaboration. RNA-Seq was provided by the Genomics Core Facility of the Case Western Reserve University (CWRU) School of Medicine's Genetics and Genome Sciences Department as well as the Northwest Genomics Center at the University of Washington. Colon artwork in the CoTrEx logo is designed by Smashicons from Flaticon (M?laga, Spain). Virginia D?ez-Obrero (Data curation: Lead; Formal analysis: Lead; Software: Lead; Visualization: Lead; Writing ? original draft: Lead), Christopher H Dampier (Data curation: Lead; Formal analysis: Equal; Writing ? original draft: Lead; Writing ? review & editing: Lead), Ferran Moratalla-Navarro (Data curation: Equal; Formal analysis: Equal; Software: Equal; Writing ? review & editing: Equal), Matthew Devall (Data curation: Equal; Formal analysis: Equal; Writing ? review & editing: Equal), Sarah J Plummer (Data curation: Equal; Resources: Lead; Writing ? review & editing: Equal), Anna D?ez-Villanueva (Formal analysis: Equal; Software: Equal; Writing ? review & editing: Equal), Ulrike Peters (Funding acquisition: Equal; Resources: Equal; Supervision: Equal; Writing ? review & editing: Equal), Stephanie Bien (Supervision: Equal; Writing ? review & editing: Equal), Jeroen R Huyghe (Supervision: Equal; Writing ? review & editing: Equal), Anshul Kundaje (Supervision: Equal), Gemma Ib??ez-Sanz (Resources: Lead; Writing ? review & editing: Equal), Elisabeth Guin? (Data curation: Lead), Mireia Ob?n-Santacana (Data curation: Equal; Writing ? review & editing: Equal), Robert Carreras-Torres (Conceptualization: Equal; Software: Equal; Supervision: Equal; Writing ? original draft: Lead; Writing ? review & editing: Lead), Graham Casey (Conceptualization: Lead; Funding acquisition: Lead; Resources: Lead; Supervision: Lead; Writing ? review & editing: Equal), Victor Moreno (Conceptualization: Lead; Funding acquisition: Lead; Resources: Lead; Software: Equal; Supervision: Lead; Writing ? review & editing: Equal) Funding Supported by the Agency for Management of University and Research Grants of the Catalan Government grants 2017SGR723; the Instituto de Salud Carlos III , co-funded by European Regional Development Fund (FEDER) funds “A Way to Build Europe” grants PI14-00613, PI17-00092; the Spanish Association Against Cancer Scientific Foundation grant GCTRA18022MORE; Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP) CB07/02/2005; and the National Institutes of Health grants R01CA204279, R01CA143237, and R01CA201407. Also supported by EU H2020 - Marie Skłodowska-Curie (MSC) grant 796216 (R.C.T.); a postdoctoral fellowship through the “Fundación Científica de la Asociación Española Contra el Cáncer (AECC)” (M.O.S.); the National Institutes of Health training grant T32 5T32CA163177-07 (C.H.D.); and the Ministerio de Universidades through predoctoral fellowship number FPU16/00599 for the “Formación del Profesorado Universitario” (V.D.O.). A sample collection of this work was supported by the Xarxa de Bancs de Tumors de Catalunya (XBTC) sponsored by Pla Director d’Oncologia de Catalunya, “Plataforma Biobancos PT13/0010/0013,” and the Biobank of the Catalan Institute of Oncology (ICOBIOBANC), sponsored by the Catalan Institute of Oncology. This work was supported in part by National Institutes of Health / National Cancer Institute grants CA143237 and CA204279 (G.C.).
| Funders | Funder number |
|---|---|
| MSc | |
| Ferran Moratalla-Navarro | |
| Catalan Institute of Oncology | |
| Instituto de Salud Carlos III | |
| Generalitat de Catalunya | |
| ICOBIOBANC | |
| Case Western Reserve University | |
| Albert Einstein Cancer Center | |
| Marie Skłodowska-Curie | |
| School of Medicine's Genetics and Genome Sciences Department | |
| Anshul Kundaje | |
| Jeroen R Huyghe | |
| Catalan Institute of Oncology Bellvitge Biomedical Research Institute | |
| University of Washington | |
| Robert Carreras-Torres | |
| Viladecans Hospital | |
| Bellvitge University Hospital | |
| National Institutes of Health training grant | T32 5T32CA163177-07 |
| Fundación Científica Asociación Española Contra el Cáncer | GCTRA18022MORE |
| Agency for Management of University and Research Grants of the Catalan Government | 2017SGR723 |
| Ministerio de Universidades | FPU16/00599 |
| National Cancer Institute | R01CA143237, R01CA204279 |
| Consortium for Biomedical Research in Epidemiology and Public Health | CB07/02/2005 |
| Xarxa de Bancs de Tumors de Catalunya | PT13/0010/0013 |
| Horizon 2020 Framework Programme | 796216 |
| National Institutes of Health | R01CA201407 |
| European Regional Development Fund | PI17-00092, PI14-00613 |
| HUB-ICO-IDIBELL | PT17/0015/0024 |